Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

Nervous system: Astrocytoma with t(1;17)(p36;q21) SPOP/PRDM16

Written2016-09Jean-Loup Huret
Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France.

(Note : for Links provided by Atlas : click)


Abstract Review on t(1;17)(p36;q21) SPOP/PRDM16 translocation in astrocytic tumor, with data on the genes involved.


ICD-Topo C710-C714,C717-C719,C720-C725,C716
ICD-Morpho 9400/3
Atlas_Id 5447
Phylum Nervous system: Central Nervous system::Astrocytic tumor
WHO/OMS Classification Nervous system

Clinics and Pathology

Disease A t(1;17)(p36;q21) was found in a case of astrocytoma grade I-II, but no further data is available (Yoshihara et al 2015).
Phenotype / cell stem origin EMBRYONIC_ORIGIN
Clinics Grade I astrocytomas are pilocytic astrocytoma and subependymal giant cell astrocytoma, the latter being the most common central nervous system neoplasm in tuberous sclerosis; they are slow growing tumors; they typically occur during the first two decades of life. Grade II astrocytomas are pilomyxoid astrocytoma occurring most often in infants and very young children, diffuse astrocytoma, seen at any age, but often between ages 30-40, and pleomorphic xanthoastrocytoma, typically developing in children and young adults.

Genes involved and Proteins

Gene NamePRDM16 (PR domain containing 16)
Location 1p36.32
Dna / Rna 11 splice variants
Protein 1276 amino acids and smaller proteins. Contains a N-term PR domain; 7 Zinc fingers, a proline-rich domain, and 3 Zinc fingers in the C-term. Binds DNA. Transcription activator; PRDM16 has an intrinsic histone methyltransferase activity. PRDM16 forms a transcriptional complex with CEBPB. PRDM16 plays a downstream regulatory role in mediating TGFB signaling (Bjork et al., 2010). PRDM16 induces brown fat determination and differentiation. PRDM16 is expressed selectively in the earliest stem and progenitor hematopoietic cells, and is required for the maintenance of the hematopoietic stem cell pool during development. PRDM16 is also required for survival, cell-cycle regulation and self-renewal in neural stem cells (Chuikov et al., 2010; Kajimura et al., 2010; Aguilo et al., 2011; Chi and Cohen, 2016).

Gene NameSPOP (speckle type BTB/POZ protein)
Location 17q21.33
Dna / Rna 24 splice variants
Protein 374 amino acids SPOP comprises a N-term MATH domain (Meprin And TRAF Homology; substrate recognition and binding), a BTB/POZ domain (Bric-a-brac, Tramtrack and Broad complex/ Pox virus and Zinc finger; connects to the CUL3 - RBX1 (Cullin 3-RING box 1) scaffold protein), a 3-box domain (facilitating CUL3 binding and resembling to F-/SOCS-boxes) and a C-terminal nuclear localization sequence. SPOP is a E3 ubiquitin ligase adaptor protein that participates in the degradation of various substrates. AR (androgen receptor), DAXX, BMI1, BRMS1 and PDX1 are targets of SPOP. SPOP is critically involved in SETD2 (a tumor suppressor) stability. SPOP enables homology-directed DNA repair of double strand breaks, and mutant SPOP promotes genomic rearrangements within chromosomes. SPOP suppresses gastric tumorigenesis through inhibiting hedgehog/ GLI2 signaling pathway. SPOP is frequently mutated in prostate and endometrial cancers. TMPRSS2 - ERG fusions, frequently seen in prostate carcinoma, encode N-terminal-truncated ERG proteins that are resistant to the SPOP-mediated degradation. Decreased expression of SPOP is associated with poor prognosis in glioma. On the other hand, SPOP is highly expressed in clear cell renal cell carcinoma (Zhuang et al., 2009; Mani, 2014; Zeng et al., 2014; Karnes et al., 2015; Ding et al., 2015; Rider and Cramer, 2015).


Prdm16 is a physiologic regulator of hematopoietic stem cells.
Aguilo F, Avagyan S, Labar A, Sevilla A, Lee DF, Kumar P, Lemischka IR, Zhou BY, Snoeck HW.
Blood. 2011 May 12;117(19):5057-66. doi: 10.1182/blood-2010-08-300145. Epub 2011 Feb 22.
PMID 21343612
Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation.
An J, Ren S, Murphy SJ, Dalangood S, Chang C, Pang X, Cui Y, Wang L, Pan Y, Zhang X, Zhu Y, Wang C, Halling GC, Cheng L, Sukov WR, Karnes RJ, Vasmatzis G, Zhang Q, Zhang J, Cheville JC, Yan J, Sun Y, Huang H.
Mol Cell. 2015 Sep 17;59(6):904-16. doi: 10.1016/j.molcel.2015.07.025. Epub 2015 Sep 3.
PMID 26344096
Prdm16 is required for normal palatogenesis in mice.
Bjork BC, Turbe-Doan A, Prysak M, Herron BJ, Beier DR.
Hum Mol Genet. 2010 Mar 1;19(5):774-89. doi: 10.1093/hmg/ddp543. Epub 2009 Dec 11.
PMID 20007998
The Multifaceted Roles of PRDM16: Adipose Biology and Beyond.
Chi J, Cohen P.
Trends Endocrinol Metab. 2016 Jan;27(1):11-23. doi: 10.1016/j.tem.2015.11.005. Epub 2015 Dec 11. Review.
PMID 26688472
Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress.
Chuikov S, Levi BP, Smith ML, Morrison SJ.
Nat Cell Biol. 2010 Oct;12(10):999-1006. doi: 10.1038/ncb2101. Epub 2010 Sep 12.
PMID 20835244
Decreased expression of the SPOP gene is associated with poor prognosis in glioma.
Ding D, Song T, Jun W, Tan Z, Fang J.
Int J Oncol. 2015 Jan;46(1):333-41. doi: 10.3892/ijo.2014.2729. Epub 2014 Oct 24.
PMID 25351530
Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex.
Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, Spiegelman BM.
Nature. 2009 Aug 27;460(7259):1154-8. Epub 2009 Jul 29.
PMID 19641492
The emerging role of speckle-type POZ protein (SPOP) in cancer development.
Mani RS.
Drug Discov Today. 2014 Sep;19(9):1498-502. doi: 10.1016/j.drudis.2014.07.009. Epub 2014 Jul 21. Review.
PMID 25058385
SPOP the mutation.
Rider L, Cramer SD.
Elife. 2015 Oct 27;4. pii: e11760. doi: 10.7554/eLife.11760.
PMID 26506153
The landscape and therapeutic relevance of cancer-associated transcript fusions.
Yoshihara K, Wang Q, Torres-Garcia W, Zheng S, Vegesna R, Kim H, Verhaak RG.
Oncogene. 2015 Sep 10;34(37):4845-54. doi: 10.1038/onc.2014.406. Epub 2014 Dec 15.
PMID 25500544
SPOP suppresses tumorigenesis by regulating Hedgehog/Gli2 signaling pathway in gastric cancer.
Zeng C, Wang Y, Lu Q, Chen J, Zhang J, Liu T, Lv N, Luo S.
J Exp Clin Cancer Res. 2014 Sep 11;33:75. doi: 10.1186/s13046-014-0075-8.
PMID 25204354
Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases.
Zhuang M, Calabrese MF, Liu J, Waddell MB, Nourse A, Hammel M, Miller DJ, Walden H, Duda DM, Seyedin SN, Hoggard T, Harper JW, White KP, Schulman BA.
Mol Cell. 2009 Oct 9;36(1):39-50. doi: 10.1016/j.molcel.2009.09.022.
PMID 19818708


This paper should be referenced as such :
Jean-Loup Huret
Nervous system: Astrocytoma with t(1;17)(p36;q21) SPOP/PRDM16
Atlas Genet Cytogenet Oncol Haematol. 2017;21(12):470-471.
Free journal version : [ pdf ]   [ DOI ]
On line version :

Translocations implicated (Data extracted from papers in the Atlas)

 t(1;17)(p36;q21) SPOP/PRDM16

External links

Mitelman database t(1;17)(p36;q21) [CaseList]     t(1;17)(p36;q21) [Transloc - MCList]   SPOP/PRDM16 Fusion - MCList]
arrayMap arrayMap ((UZH-SIB Zurich)   [auto + random 100 samples .. if exist ]   [tabulated segments]
Disease databaseNervous system: Astrocytoma with t(1;17)(p36;q21) SPOP/PRDM16
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Sat Dec 5 18:43:58 CET 2020

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us